Company Filing History:
Years Active: 2011-2016
Title: Rouli Zhou: Innovator in Cancer Research
Introduction
Rouli Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research through his innovative work on human cancer-related genes. With a total of 2 patents, Zhou's inventions are paving the way for new anti-cancer approaches and medicines.
Latest Patents
Zhou's latest patents focus on the human cancer-related gene LAPTM4B and its encoded products. The inventions disclose various nucleotide sequences that are crucial for understanding cancer biology. These sequences include SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, and SEQ ID No: 8. Additionally, the patents cover polynucleotides that encode specific protein sequences and DNA sequences with over 90% homology to the specified sequences. The implications of these inventions are profound, as they enable the development of new anti-cancer approaches and medicines that could significantly impact human society.
Career Highlights
Rouli Zhou is affiliated with Peking University, where he continues to advance his research in cancer genetics. His work is characterized by a commitment to innovation and a focus on practical applications that can benefit patients and the medical community.
Collaborations
Zhou collaborates with notable colleagues such as Genze Shao and Xinrong Liu. These partnerships enhance the research efforts and contribute to the overall success of their projects.
Conclusion
Rouli Zhou's contributions to cancer research through his patents and collaborations highlight the importance of innovation in the medical field. His work not only advances scientific knowledge but also holds the potential to improve treatment options for cancer patients.